FDA Clearance Tracker · P040014-S008
THERAPY CARDIAC ABLATION CATHETERS
Last checked: Nov 20, 2026Latest source record: Jun 17, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Jun 17, 2009
Approved
Time to decision
286 days
Received Sep 4, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040014-S008
- Device name
- THERAPY CARDIAC ABLATION CATHETERS
- Applicant
- Irvine Biomedical, Inc.
- Applicant location
- Irvine, CA
- Received
- Sep 4, 2008
- Decided
- Jun 17, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040014
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR SOFTWARE CHANGES IN THE IBI 1500T9 RF GENERATOR WITH SOFTWARE VERSION 1.42.
Source documents
Other decisions for Irvine Biomedical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.